Research Article
A New and Simple Risk Predictor of Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention: TIMI Risk Index
Table 3
Comparison of angiographic and treatment variables of patients with and without CIN after PCI.
| | Variables | CIN (−) () | CIN (+) () | value |
| | Amount of contrast media | 232 ± 66 | 290 ± 89 | <0.001 | | Previous medications, % | | | | | Acetylsalicylic acid | 13.8 | 9.4 | 0.171 | | Statin | 19.4 | 8,5 | 0.037 | | ACE inhibitors/ARB | 19.5 | 14.4 | 0.192 | | Beta-blocker | 5 | 4.7 | 0.868 | | Calcium channel blocker | 5 | 8 | 0.267 | | Oral antidiabetic | 15 | 21.9 | 0.047 | | Insulin | 5.7 | 21.1 | <0.001 | | Infarct-related artery, ( %) | LM | 3 (0.4) | 1 (0.1) | 0.155 | | LAD | 400 (47.9) | 68 (53.1) | | LCx | 132 (15.8) | 10 (7.8) | | RCA | 289 (34.6) | 49 (38.3) | | Other | 11 (1.3) | — | | Syntax score, % | 15.4 ± 6.8 | 16.8 ± 8.6 | 0.035 | | TIMI flow 3, (, %) | 775 (92) | 101 (79) | <0.001 |
|
|
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; LM, left main; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery; TIMI, thrombolysis in myocardial infarction.
|
